BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4901484)

  • 21. [Chronobiological study of free thyroid hormones in hypothyroid and hyperthyroid subjects].
    De Remigis P; Damiani A; Menduni P; Guagnano MT; Vianale L; D'Angelo M; Bonaduce A; Di Sciascio F; Liberatoscioli C; Sensi S
    Boll Soc Ital Biol Sper; 1983 Jan; 59(1):33-5. PubMed ID: 6849692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in plasma homocysteine levels of rats with experimentally induced hypothyroidism and hyperthyroidism.
    Ozkan Y; Dönder E; Güney H; Baydaş G
    Neuro Endocrinol Lett; 2005 Oct; 26(5):536-40. PubMed ID: 16264404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Plasma levels of testosterone production in male thyrotoxicosis].
    Mowszowicz I; Dray F
    Ann Biol Clin (Paris); 1967; 25(7):879-88. PubMed ID: 4864783
    [No Abstract]   [Full Text] [Related]  

  • 24. Thirty-five cases of transient hyperthyroidism.
    McConnon JK
    Can Med Assoc J; 1984 May; 130(9):1159-61. PubMed ID: 6546896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evolution of serum gammaglutamyl transpeptidase activity in treated hyperthyroid and hypothyroid patients].
    Couzigou P; Latapie JL; Fleury B; Climas MT; Le Moigne F; Crockett E; Sauneron MF; Richard-Molard B; Amouretti M; Béraud C
    Gastroenterol Clin Biol; 1984 May; 8(5):458-63. PubMed ID: 6145651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased plasma levels of endothelin-1 in patients with hyperthyroidism.
    Letizia C; Centanni M; Cesareo R; De Ciocchis A; Cerci S; Scuro L; Fumarola A; D'Ambrosio C; Scavo D
    Metabolism; 1995 Oct; 44(10):1239-42. PubMed ID: 7476277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. gamma-Glutamyl transpeptidase levels in thyroid disease.
    Azizi F
    Arch Intern Med; 1982 Jan; 142(1):79-81. PubMed ID: 6119059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score.
    Strieder TG; Tijssen JG; Wenzel BE; Endert E; Wiersinga WM
    Arch Intern Med; 2008 Aug; 168(15):1657-63. PubMed ID: 18695079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term follow-up of treated hyperthyroid and hypothyroid patients.
    Leese GP; Jung RT; Scott A; Waugh N; Browning MC
    Health Bull (Edinb); 1993 May; 51(3):177-83. PubMed ID: 8325778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The metabolism of organic iodine in man studied with L-thyroxine-I-131. Preliminary studies].
    Casson F; Busnardo B; Scarpa R
    Acta Isot (Padova); 1966 Dec; 6(2):149-57. PubMed ID: 4869186
    [No Abstract]   [Full Text] [Related]  

  • 31. Normalized resin uptake of displaced 125 I-T 4 using denatured serum.
    Mitchell ML
    J Nucl Med; 1973 Jun; 14(6):336-40. PubMed ID: 4633859
    [No Abstract]   [Full Text] [Related]  

  • 32. Measurement of serum free thyroxine by RIA in various clinical states.
    Braverman LE; Abreau CM; Brock P; Kleinmann R; Fournier L; Odstrchel G; Schoemaker HJ
    J Nucl Med; 1980 Mar; 21(3):233-9. PubMed ID: 6767812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of experimental hypo- and hyperthyroidism on serum adiponectin.
    Aragão CN; Souza LL; Cabanelas A; Oliveira KJ; Pazos-Moura CC
    Metabolism; 2007 Jan; 56(1):6-11. PubMed ID: 17161219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Frequency of the exophthalmos-producing factor (EPS) in clinical forms of exophthalmos].
    Stancu H; Dancăşiu M; Bălan M; Negoescu I
    Stud Cercet Endocrinol; 1969; 20(2):157-62. PubMed ID: 5394446
    [No Abstract]   [Full Text] [Related]  

  • 35. The clinical significance of plasma thyroid-stimulating ctivity in hyperthyroidism.
    Hoffmann MJ; Hetzel BS
    Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4169740
    [No Abstract]   [Full Text] [Related]  

  • 36. The clinical significance of plasma thyroid-stimulating activity in hyperthyroidism.
    Hoffmann MJ; Hetzel BS
    Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4168752
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of the plasma thyrotropin in thyroid diseases].
    Lemarchand-Béraud T; Scazziga BR; Vannotti A
    Schweiz Med Wochenschr; 1966 Jun; 96(22):718-22. PubMed ID: 5988345
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of osteopontin in patients with thyroid dysfunction.
    Reza S; Shaukat A; Arain TM; Riaz QS; Mahmud M
    PLoS One; 2013; 8(2):e56533. PubMed ID: 23437160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of triiodothyronine in the evaluation of thyroid function after treatment for hyperthyroidism.
    Smeulers J; Docter R; Visser TJ; Hennemann G
    Neth J Med; 1980; 23(1):18-22. PubMed ID: 6154249
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dynamics of the serum lipid indices in thyrotoxicosis].
    Tsanev A; Khlebarova M; Dishlianova B; Zlateva S
    Vutr Boles; 1984; 23(3):94-9. PubMed ID: 6547793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.